nodes	percent_of_prediction	percent_of_DWPC	metapath
Enzalutamide—ABCB1—peripheral nervous system neoplasm	0.341	1	CbGaD
Enzalutamide—CYP2B6—Tretinoin—peripheral nervous system neoplasm	0.0617	0.118	CbGbCtD
Enzalutamide—CYP3A5—Tretinoin—peripheral nervous system neoplasm	0.0486	0.0931	CbGbCtD
Enzalutamide—CYP2C8—Tretinoin—peripheral nervous system neoplasm	0.0467	0.0895	CbGbCtD
Enzalutamide—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.034	0.0652	CbGbCtD
Enzalutamide—ABCB1—Topotecan—peripheral nervous system neoplasm	0.034	0.0652	CbGbCtD
Enzalutamide—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0326	0.0624	CbGbCtD
Enzalutamide—CYP2B6—Cisplatin—peripheral nervous system neoplasm	0.0264	0.0506	CbGbCtD
Enzalutamide—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0236	0.0452	CbGbCtD
Enzalutamide—CYP3A5—Vincristine—peripheral nervous system neoplasm	0.0223	0.0427	CbGbCtD
Enzalutamide—CYP3A5—Etoposide—peripheral nervous system neoplasm	0.0204	0.0392	CbGbCtD
Enzalutamide—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0204	0.039	CbGbCtD
Enzalutamide—CYP2C8—Etoposide—peripheral nervous system neoplasm	0.0196	0.0377	CbGbCtD
Enzalutamide—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0189	0.0363	CbGbCtD
Enzalutamide—CYP2B6—Doxorubicin—peripheral nervous system neoplasm	0.0177	0.0339	CbGbCtD
Enzalutamide—ABCB1—Vincristine—peripheral nervous system neoplasm	0.0145	0.0278	CbGbCtD
Enzalutamide—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.0139	0.0267	CbGbCtD
Enzalutamide—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.0135	0.0259	CbGbCtD
Enzalutamide—ABCB1—Etoposide—peripheral nervous system neoplasm	0.0133	0.0255	CbGbCtD
Enzalutamide—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00907	0.0174	CbGbCtD
Enzalutamide—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0087	0.0167	CbGbCtD
Enzalutamide—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.00855	0.0164	CbGbCtD
Enzalutamide—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00797	0.0153	CbGbCtD
Enzalutamide—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00543	0.0104	CbGbCtD
Enzalutamide—Convulsion—Melphalan—peripheral nervous system neoplasm	0.000459	0.00333	CcSEcCtD
Enzalutamide—Urethral disorder—Alitretinoin—peripheral nervous system neoplasm	0.000458	0.00333	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Topotecan—peripheral nervous system neoplasm	0.000457	0.00332	CcSEcCtD
Enzalutamide—Arthralgia—Tretinoin—peripheral nervous system neoplasm	0.000457	0.00332	CcSEcCtD
Enzalutamide—Arthralgia—Isotretinoin—peripheral nervous system neoplasm	0.000457	0.00332	CcSEcCtD
Enzalutamide—Anxiety—Tretinoin—peripheral nervous system neoplasm	0.000455	0.00331	CcSEcCtD
Enzalutamide—Anxiety—Isotretinoin—peripheral nervous system neoplasm	0.000455	0.00331	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Tretinoin—peripheral nervous system neoplasm	0.000454	0.0033	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Isotretinoin—peripheral nervous system neoplasm	0.000454	0.0033	CcSEcCtD
Enzalutamide—Hypoaesthesia—Vincristine—peripheral nervous system neoplasm	0.000448	0.00325	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Melphalan—peripheral nervous system neoplasm	0.000448	0.00325	CcSEcCtD
Enzalutamide—Urinary tract disorder—Vincristine—peripheral nervous system neoplasm	0.000445	0.00323	CcSEcCtD
Enzalutamide—Connective tissue disorder—Vincristine—peripheral nervous system neoplasm	0.000442	0.00321	CcSEcCtD
Enzalutamide—Urethral disorder—Vincristine—peripheral nervous system neoplasm	0.000441	0.00321	CcSEcCtD
Enzalutamide—Infection—Topotecan—peripheral nervous system neoplasm	0.000439	0.00319	CcSEcCtD
Enzalutamide—Infection—Isotretinoin—peripheral nervous system neoplasm	0.000435	0.00316	CcSEcCtD
Enzalutamide—Infection—Tretinoin—peripheral nervous system neoplasm	0.000435	0.00316	CcSEcCtD
Enzalutamide—Nervous system disorder—Topotecan—peripheral nervous system neoplasm	0.000433	0.00315	CcSEcCtD
Enzalutamide—Thrombocytopenia—Topotecan—peripheral nervous system neoplasm	0.000432	0.00314	CcSEcCtD
Enzalutamide—Nervous system disorder—Tretinoin—peripheral nervous system neoplasm	0.000429	0.00312	CcSEcCtD
Enzalutamide—Nervous system disorder—Isotretinoin—peripheral nervous system neoplasm	0.000429	0.00312	CcSEcCtD
Enzalutamide—Infection—Melphalan—peripheral nervous system neoplasm	0.000429	0.00312	CcSEcCtD
Enzalutamide—Skin disorder—Topotecan—peripheral nervous system neoplasm	0.000429	0.00312	CcSEcCtD
Enzalutamide—Thrombocytopenia—Isotretinoin—peripheral nervous system neoplasm	0.000429	0.00312	CcSEcCtD
Enzalutamide—Thrombocytopenia—Tretinoin—peripheral nervous system neoplasm	0.000429	0.00312	CcSEcCtD
Enzalutamide—Neutropenia—Etoposide—peripheral nervous system neoplasm	0.000426	0.0031	CcSEcCtD
Enzalutamide—Skin disorder—Tretinoin—peripheral nervous system neoplasm	0.000425	0.00309	CcSEcCtD
Enzalutamide—Skin disorder—Isotretinoin—peripheral nervous system neoplasm	0.000425	0.00309	CcSEcCtD
Enzalutamide—Angiopathy—Alitretinoin—peripheral nervous system neoplasm	0.000424	0.00308	CcSEcCtD
Enzalutamide—Thrombocytopenia—Melphalan—peripheral nervous system neoplasm	0.000423	0.00307	CcSEcCtD
Enzalutamide—Skin disorder—Melphalan—peripheral nervous system neoplasm	0.00042	0.00305	CcSEcCtD
Enzalutamide—Musculoskeletal pain—Epirubicin—peripheral nervous system neoplasm	0.000412	0.00299	CcSEcCtD
Enzalutamide—Mental disorder—Alitretinoin—peripheral nervous system neoplasm	0.000409	0.00297	CcSEcCtD
Enzalutamide—Pneumonia—Etoposide—peripheral nervous system neoplasm	0.000409	0.00297	CcSEcCtD
Enzalutamide—Angiopathy—Vincristine—peripheral nervous system neoplasm	0.000408	0.00297	CcSEcCtD
Enzalutamide—Infestation NOS—Etoposide—peripheral nervous system neoplasm	0.000406	0.00295	CcSEcCtD
Enzalutamide—Infestation—Etoposide—peripheral nervous system neoplasm	0.000406	0.00295	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Topotecan—peripheral nervous system neoplasm	0.000402	0.00292	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Tretinoin—peripheral nervous system neoplasm	0.000399	0.0029	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Isotretinoin—peripheral nervous system neoplasm	0.000399	0.0029	CcSEcCtD
Enzalutamide—Paraesthesia—Topotecan—peripheral nervous system neoplasm	0.000396	0.00288	CcSEcCtD
Enzalutamide—Insomnia—Isotretinoin—peripheral nervous system neoplasm	0.000396	0.00288	CcSEcCtD
Enzalutamide—Insomnia—Tretinoin—peripheral nervous system neoplasm	0.000396	0.00288	CcSEcCtD
Enzalutamide—Mental disorder—Vincristine—peripheral nervous system neoplasm	0.000394	0.00287	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Melphalan—peripheral nervous system neoplasm	0.000394	0.00286	CcSEcCtD
Enzalutamide—Back pain—Alitretinoin—peripheral nervous system neoplasm	0.000393	0.00286	CcSEcCtD
Enzalutamide—Paraesthesia—Tretinoin—peripheral nervous system neoplasm	0.000393	0.00286	CcSEcCtD
Enzalutamide—Paraesthesia—Isotretinoin—peripheral nervous system neoplasm	0.000393	0.00286	CcSEcCtD
Enzalutamide—Urinary tract disorder—Cisplatin—peripheral nervous system neoplasm	0.000393	0.00286	CcSEcCtD
Enzalutamide—Leukopenia—Dactinomycin—peripheral nervous system neoplasm	0.000393	0.00285	CcSEcCtD
Enzalutamide—Connective tissue disorder—Cisplatin—peripheral nervous system neoplasm	0.000391	0.00284	CcSEcCtD
Enzalutamide—Urethral disorder—Cisplatin—peripheral nervous system neoplasm	0.00039	0.00283	CcSEcCtD
Enzalutamide—Paraesthesia—Melphalan—peripheral nervous system neoplasm	0.000388	0.00282	CcSEcCtD
Enzalutamide—Musculoskeletal pain—Doxorubicin—peripheral nervous system neoplasm	0.000381	0.00277	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Topotecan—peripheral nervous system neoplasm	0.000381	0.00277	CcSEcCtD
Enzalutamide—Fatigue—Topotecan—peripheral nervous system neoplasm	0.000381	0.00277	CcSEcCtD
Enzalutamide—Back pain—Vincristine—peripheral nervous system neoplasm	0.000379	0.00275	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Isotretinoin—peripheral nervous system neoplasm	0.000378	0.00275	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Tretinoin—peripheral nervous system neoplasm	0.000378	0.00275	CcSEcCtD
Enzalutamide—Fatigue—Tretinoin—peripheral nervous system neoplasm	0.000378	0.00274	CcSEcCtD
Enzalutamide—Fatigue—Isotretinoin—peripheral nervous system neoplasm	0.000378	0.00274	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Melphalan—peripheral nervous system neoplasm	0.000373	0.00271	CcSEcCtD
Enzalutamide—Fatigue—Melphalan—peripheral nervous system neoplasm	0.000373	0.00271	CcSEcCtD
Enzalutamide—Hypoaesthesia—Etoposide—peripheral nervous system neoplasm	0.000363	0.00264	CcSEcCtD
Enzalutamide—Urinary tract disorder—Etoposide—peripheral nervous system neoplasm	0.00036	0.00262	CcSEcCtD
Enzalutamide—Urethral disorder—Etoposide—peripheral nervous system neoplasm	0.000357	0.0026	CcSEcCtD
Enzalutamide—Infection—Dactinomycin—peripheral nervous system neoplasm	0.000356	0.00258	CcSEcCtD
Enzalutamide—Sepsis—Epirubicin—peripheral nervous system neoplasm	0.000353	0.00257	CcSEcCtD
Enzalutamide—Convulsion—Alitretinoin—peripheral nervous system neoplasm	0.000352	0.00256	CcSEcCtD
Enzalutamide—Vertigo—Vincristine—peripheral nervous system neoplasm	0.000352	0.00256	CcSEcCtD
Enzalutamide—Hypertension—Alitretinoin—peripheral nervous system neoplasm	0.000351	0.00255	CcSEcCtD
Enzalutamide—Leukopenia—Vincristine—peripheral nervous system neoplasm	0.000351	0.00255	CcSEcCtD
Enzalutamide—Thrombocytopenia—Dactinomycin—peripheral nervous system neoplasm	0.00035	0.00255	CcSEcCtD
Enzalutamide—Arthralgia—Alitretinoin—peripheral nervous system neoplasm	0.000346	0.00252	CcSEcCtD
Enzalutamide—Anxiety—Alitretinoin—peripheral nervous system neoplasm	0.000345	0.00251	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Alitretinoin—peripheral nervous system neoplasm	0.000344	0.0025	CcSEcCtD
Enzalutamide—Convulsion—Vincristine—peripheral nervous system neoplasm	0.00034	0.00247	CcSEcCtD
Enzalutamide—Hypertension—Vincristine—peripheral nervous system neoplasm	0.000338	0.00246	CcSEcCtD
Enzalutamide—Angiopathy—Etoposide—peripheral nervous system neoplasm	0.000331	0.0024	CcSEcCtD
Enzalutamide—Infection—Alitretinoin—peripheral nervous system neoplasm	0.00033	0.0024	CcSEcCtD
Enzalutamide—Sepsis—Doxorubicin—peripheral nervous system neoplasm	0.000327	0.00237	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Dactinomycin—peripheral nervous system neoplasm	0.000326	0.00237	CcSEcCtD
Enzalutamide—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.000325	0.00236	CcSEcCtD
Enzalutamide—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	0.000325	0.00236	CcSEcCtD
Enzalutamide—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.000322	0.00234	CcSEcCtD
Enzalutamide—Infection—Vincristine—peripheral nervous system neoplasm	0.000318	0.00231	CcSEcCtD
Enzalutamide—Asthenia—Topotecan—peripheral nervous system neoplasm	0.000317	0.0023	CcSEcCtD
Enzalutamide—Hot flush—Epirubicin—peripheral nervous system neoplasm	0.000316	0.00229	CcSEcCtD
Enzalutamide—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.000314	0.00228	CcSEcCtD
Enzalutamide—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.000314	0.00228	CcSEcCtD
Enzalutamide—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.000314	0.00228	CcSEcCtD
Enzalutamide—Menopausal symptoms—Epirubicin—peripheral nervous system neoplasm	0.000313	0.00228	CcSEcCtD
Enzalutamide—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.000313	0.00227	CcSEcCtD
Enzalutamide—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000312	0.00227	CcSEcCtD
Enzalutamide—Leukopenia—Cisplatin—peripheral nervous system neoplasm	0.00031	0.00225	CcSEcCtD
Enzalutamide—Asthenia—Melphalan—peripheral nervous system neoplasm	0.00031	0.00225	CcSEcCtD
Enzalutamide—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.00031	0.00225	CcSEcCtD
Enzalutamide—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.00031	0.00225	CcSEcCtD
Enzalutamide—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.000309	0.00224	CcSEcCtD
Enzalutamide—Back pain—Etoposide—peripheral nervous system neoplasm	0.000307	0.00223	CcSEcCtD
Enzalutamide—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000306	0.00222	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.000302	0.0022	CcSEcCtD
Enzalutamide—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000302	0.00219	CcSEcCtD
Enzalutamide—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.0003	0.00218	CcSEcCtD
Enzalutamide—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.0003	0.00218	CcSEcCtD
Enzalutamide—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.0003	0.00218	CcSEcCtD
Enzalutamide—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.0003	0.00218	CcSEcCtD
Enzalutamide—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.000298	0.00217	CcSEcCtD
Enzalutamide—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000296	0.00215	CcSEcCtD
Enzalutamide—Anxiety—Cisplatin—peripheral nervous system neoplasm	0.000294	0.00214	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.000293	0.00213	CcSEcCtD
Enzalutamide—Hot flush—Doxorubicin—peripheral nervous system neoplasm	0.000292	0.00212	CcSEcCtD
Enzalutamide—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000292	0.00212	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000291	0.00212	CcSEcCtD
Enzalutamide—Menopausal symptoms—Doxorubicin—peripheral nervous system neoplasm	0.00029	0.00211	CcSEcCtD
Enzalutamide—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00029	0.0021	CcSEcCtD
Enzalutamide—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00029	0.0021	CcSEcCtD
Enzalutamide—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000289	0.0021	CcSEcCtD
Enzalutamide—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000287	0.00209	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000287	0.00208	CcSEcCtD
Enzalutamide—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000286	0.00208	CcSEcCtD
Enzalutamide—Vertigo—Etoposide—peripheral nervous system neoplasm	0.000285	0.00207	CcSEcCtD
Enzalutamide—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.000284	0.00206	CcSEcCtD
Enzalutamide—Infection—Cisplatin—peripheral nervous system neoplasm	0.000281	0.00204	CcSEcCtD
Enzalutamide—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000277	0.00201	CcSEcCtD
Enzalutamide—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000277	0.00201	CcSEcCtD
Enzalutamide—Headache—Topotecan—peripheral nervous system neoplasm	0.000277	0.00201	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000276	0.00201	CcSEcCtD
Enzalutamide—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000276	0.002	CcSEcCtD
Enzalutamide—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000275	0.002	CcSEcCtD
Enzalutamide—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000275	0.002	CcSEcCtD
Enzalutamide—Headache—Tretinoin—peripheral nervous system neoplasm	0.000274	0.00199	CcSEcCtD
Enzalutamide—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000274	0.00199	CcSEcCtD
Enzalutamide—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000274	0.00199	CcSEcCtD
Enzalutamide—Dry skin—Epirubicin—peripheral nervous system neoplasm	0.000271	0.00197	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000268	0.00195	CcSEcCtD
Enzalutamide—Nasopharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000264	0.00192	CcSEcCtD
Enzalutamide—Muscular weakness—Epirubicin—peripheral nervous system neoplasm	0.000261	0.00189	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000258	0.00187	CcSEcCtD
Enzalutamide—Infection—Etoposide—peripheral nervous system neoplasm	0.000257	0.00187	CcSEcCtD
Enzalutamide—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000257	0.00187	CcSEcCtD
Enzalutamide—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000254	0.00184	CcSEcCtD
Enzalutamide—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000254	0.00184	CcSEcCtD
Enzalutamide—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000252	0.00183	CcSEcCtD
Enzalutamide—Dry skin—Doxorubicin—peripheral nervous system neoplasm	0.000251	0.00182	CcSEcCtD
Enzalutamide—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.000246	0.00178	CcSEcCtD
Enzalutamide—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000245	0.00178	CcSEcCtD
Enzalutamide—Nasopharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000244	0.00178	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000244	0.00177	CcSEcCtD
Enzalutamide—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.000241	0.00175	CcSEcCtD
Enzalutamide—Neutropenia—Epirubicin—peripheral nervous system neoplasm	0.000239	0.00173	CcSEcCtD
Enzalutamide—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000238	0.00173	CcSEcCtD
Enzalutamide—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.000237	0.00172	CcSEcCtD
Enzalutamide—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.000236	0.00171	CcSEcCtD
Enzalutamide—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000235	0.00171	CcSEcCtD
Enzalutamide—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000233	0.00169	CcSEcCtD
Enzalutamide—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000229	0.00167	CcSEcCtD
Enzalutamide—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.000229	0.00166	CcSEcCtD
Enzalutamide—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000228	0.00165	CcSEcCtD
Enzalutamide—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000228	0.00165	CcSEcCtD
Enzalutamide—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000227	0.00165	CcSEcCtD
Enzalutamide—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000227	0.00165	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000224	0.00162	CcSEcCtD
Enzalutamide—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000223	0.00162	CcSEcCtD
Enzalutamide—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	0.000221	0.00161	CcSEcCtD
Enzalutamide—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.00022	0.0016	CcSEcCtD
Enzalutamide—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000219	0.00159	CcSEcCtD
Enzalutamide—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000219	0.00159	CcSEcCtD
Enzalutamide—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000218	0.00159	CcSEcCtD
Enzalutamide—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000217	0.00158	CcSEcCtD
Enzalutamide—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000215	0.00156	CcSEcCtD
Enzalutamide—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000214	0.00155	CcSEcCtD
Enzalutamide—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.000212	0.00154	CcSEcCtD
Enzalutamide—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000211	0.00154	CcSEcCtD
Enzalutamide—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000211	0.00153	CcSEcCtD
Enzalutamide—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000211	0.00153	CcSEcCtD
Enzalutamide—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000208	0.00151	CcSEcCtD
Enzalutamide—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000205	0.00149	CcSEcCtD
Enzalutamide—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000203	0.00148	CcSEcCtD
Enzalutamide—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000203	0.00147	CcSEcCtD
Enzalutamide—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000203	0.00147	CcSEcCtD
Enzalutamide—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000202	0.00147	CcSEcCtD
Enzalutamide—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000201	0.00146	CcSEcCtD
Enzalutamide—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000201	0.00146	CcSEcCtD
Enzalutamide—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000201	0.00146	CcSEcCtD
Enzalutamide—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.0002	0.00146	CcSEcCtD
Enzalutamide—Headache—Vincristine—peripheral nervous system neoplasm	0.0002	0.00146	CcSEcCtD
Enzalutamide—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000199	0.00144	CcSEcCtD
Enzalutamide—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000198	0.00144	CcSEcCtD
Enzalutamide—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000193	0.00141	CcSEcCtD
Enzalutamide—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.00019	0.00138	CcSEcCtD
Enzalutamide—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000188	0.00137	CcSEcCtD
Enzalutamide—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000188	0.00136	CcSEcCtD
Enzalutamide—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000187	0.00136	CcSEcCtD
Enzalutamide—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000186	0.00135	CcSEcCtD
Enzalutamide—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000186	0.00135	CcSEcCtD
Enzalutamide—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000186	0.00135	CcSEcCtD
Enzalutamide—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000185	0.00135	CcSEcCtD
Enzalutamide—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000185	0.00135	CcSEcCtD
Enzalutamide—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000183	0.00133	CcSEcCtD
Enzalutamide—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000179	0.0013	CcSEcCtD
Enzalutamide—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000177	0.00129	CcSEcCtD
Enzalutamide—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000172	0.00125	CcSEcCtD
Enzalutamide—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000172	0.00125	CcSEcCtD
Enzalutamide—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000171	0.00124	CcSEcCtD
Enzalutamide—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000166	0.0012	CcSEcCtD
Enzalutamide—Headache—Etoposide—peripheral nervous system neoplasm	0.000162	0.00118	CcSEcCtD
Enzalutamide—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.00016	0.00116	CcSEcCtD
Enzalutamide—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000159	0.00116	CcSEcCtD
Enzalutamide—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000159	0.00116	CcSEcCtD
Enzalutamide—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000154	0.00112	CcSEcCtD
Enzalutamide—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000154	0.00112	CcSEcCtD
Enzalutamide—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000151	0.0011	CcSEcCtD
Enzalutamide—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000151	0.0011	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.00015	0.00109	CcSEcCtD
Enzalutamide—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.00107	CcSEcCtD
Enzalutamide—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000147	0.00107	CcSEcCtD
Enzalutamide—Infection—Epirubicin—peripheral nervous system neoplasm	0.000144	0.00105	CcSEcCtD
Enzalutamide—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000143	0.00104	CcSEcCtD
Enzalutamide—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000142	0.00103	CcSEcCtD
Enzalutamide—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000142	0.00103	CcSEcCtD
Enzalutamide—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000142	0.00103	CcSEcCtD
Enzalutamide—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000141	0.00102	CcSEcCtD
Enzalutamide—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.00014	0.00102	CcSEcCtD
Enzalutamide—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.00014	0.00101	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000139	0.00101	CcSEcCtD
Enzalutamide—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000133	0.00097	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000132	0.000961	CcSEcCtD
Enzalutamide—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000957	CcSEcCtD
Enzalutamide—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000956	CcSEcCtD
Enzalutamide—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000131	0.000954	CcSEcCtD
Enzalutamide—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000131	0.000948	CcSEcCtD
Enzalutamide—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.00013	0.000947	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000125	0.000911	CcSEcCtD
Enzalutamide—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000125	0.00091	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000122	0.000889	CcSEcCtD
Enzalutamide—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000122	0.000883	CcSEcCtD
Enzalutamide—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.000877	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.000843	CcSEcCtD
Enzalutamide—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.000842	CcSEcCtD
Enzalutamide—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000757	CcSEcCtD
Enzalutamide—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000746	CcSEcCtD
Enzalutamide—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	9.94e-05	0.000722	CcSEcCtD
Enzalutamide—Asthenia—Doxorubicin—peripheral nervous system neoplasm	9.64e-05	0.0007	CcSEcCtD
Enzalutamide—Dizziness—Epirubicin—peripheral nervous system neoplasm	9.6e-05	0.000698	CcSEcCtD
Enzalutamide—Pruritus—Doxorubicin—peripheral nervous system neoplasm	9.51e-05	0.000691	CcSEcCtD
Enzalutamide—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	9.19e-05	0.000668	CcSEcCtD
Enzalutamide—Headache—Epirubicin—peripheral nervous system neoplasm	9.1e-05	0.000661	CcSEcCtD
Enzalutamide—Dizziness—Doxorubicin—peripheral nervous system neoplasm	8.89e-05	0.000646	CcSEcCtD
Enzalutamide—Headache—Doxorubicin—peripheral nervous system neoplasm	8.42e-05	0.000612	CcSEcCtD
